GNRSU drops to USD 0.000001 on 02 Jan 2026: PNK top loser, liquidity warning
GNRSU (The Greenrose Holding Company Inc.) plunged to USD 0.000001 on 02 Jan 2026 during market hours on the PNK exchange, representing a decline of about -99.99% from the previous close of USD 0.15. The move left a market cap near USD 13.00 and traded just 145 shares, making GNRSU one of today’s top losers by percentage. Low liquidity, sharp price gaps and mixed balance‑sheet metrics explain why traders flagged GNRSU as high risk. This piece uses Meyka AI’s data to frame the drop, valuation oddities and scenario price targets for investors watching microcap cannabis stocks in the United States.
What drove today’s decline
GNRSU’s slide to USD 0.000001 came on extremely light volume of 145 shares versus no listed average volume, so a small trade produced a large price move. The stock opened at USD 0.000001, recorded the same intraday high and low, and closed sharply below the prior close of USD 0.15. With shares outstanding at 12,853,627 and a quoted market cap near USD 13.00, this pattern is typical of thinly traded PNK microcaps where single trades create outsized percentage changes.
Financial snapshot and valuation signals
The Greenrose Holding Company Inc. reports EPS of 3.10 (TTM) and a reported PE that is effectively zero on the quote feed, a quirk tied to the current quoted price of USD 0.000001. Book value per share is USD 4.30 while shareholders’ equity per share is USD 4.30, contrasting sharply with the quoted market cap. Key ratios: current ratio 0.21, debt to equity 1.57, days of inventory on hand 439.24, and gross profit margin 59.05%. These mixed signals—positive margins but low liquidity and high inventory days—raise valuation and operational questions for analysts.
Technical picture and liquidity risk
Technically GNRSU shows extreme volatility and a broken price structure: year high USD 0.15, year low USD 0.000001, and 50/200‑day averages around USD 0.15. Average volume is not reported, so order book depth is unreliable. For active traders, the main risk is execution: large orders will move price sharply, and bid/ask spreads are likely wide. Risk management requires position size limits and strict stop rules when trading this name on PNK.
Meyka AI grade, analyst framing and price scenarios
Meyka AI rates GNRSU with a score out of 100: Score: 67.22623085761357 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Scenario price targets (scenario‑based, not analyst consensus): Bear: USD 0.000001 (current, low liquidity case); Base: USD 0.01 (partial recovery if liquidity and listing normalize); Bull: USD 0.10 (material operational recovery and market re‑rating). These targets are illustrative, based on balance sheet recovery and trading normalization rather than published analyst coverage.
Sector context, catalysts and risks
GNRSU operates in Healthcare, within Drug Manufacturers – Specialty & Generic, focused on cannabis cultivation and processing. Sector headwinds include regulatory changes, state market dynamics and capital constraints for small growers. Company facts: CEO Nicole Conboy, HQ Amityville NY, 91 employees and website https://www.greenroseholdings.com. Key near‑term catalysts would be audited filings, clearer liquidity or a market re‑listing; primary risks are delisting, low free float, and working capital shortfalls (working capital reported as -USD 103,434,000).
Final Thoughts
Key takeaways: GNRSU’s drop to USD 0.000001 on 02 Jan 2026 is driven by extreme illiquidity and a small executed volume of 145 shares; the quoted market cap of roughly USD 13.00 and the gap versus book value per share (USD 4.30) create a large valuation disconnect. Traders should treat GNRSU as a high‑volatility microcap on the PNK exchange in the United States, with execution and delisting risk paramount. Meyka AI’s grading places GNRSU at a B (score 67.23) with a HOLD suggestion, reflecting mixed operational metrics but major market structure risk. Meyka AI’s forecast model projects a yearly figure of USD 0.00, which compared to the current price of USD 0.000001 implies an implied downside of -100.00% in that scenario; forecasts are model‑based projections and not guarantees. Scenario price targets range from USD 0.000001 in the bear case to USD 0.10 in a rare operational turnaround; investors should require clearer filings and liquidity before increasing exposure.
FAQs
The decline reflects extremely low liquidity (145 shares traded), a single small trade moving the quoted price to USD 0.000001 and a wide gap from the prior close of USD 0.15. Thin order books on PNK amplify percentage moves.
GNRSU is high risk. Meyka AI assigns a B grade with a HOLD suggestion. The stock carries execution, delisting and financial reporting risks. Buyers should wait for audited filings, better volume and clearer catalysts.
Check the company website (https://www.greenroseholdings.com) and official SEC filings if available. For microcaps, also review PNK exchange notices and press releases for corporate updates.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
